Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21915712 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: IRX-2;   Drug: Cyclophosphamide;   Drug: Indomethacin;   Drug: Zinc;   Drug: Omeprazole

Indicates status has not been verified in more than two years